论文部分内容阅读
Anthracyclines are considered to be some of the most effective anticancer drugs for cancer therapy,but are limited by drug-resistance and cardiotoxicity.To overcome drug resistance,we designed a 3-azido analogue of Epirubicin(AEPI)based on molecular docking with multidrug-resistance protein Sav1866.AEPI was synthesized through transforming the amino group of Epirubicin to an azido group.